Hythiam granted European patent for alcohol treatment protocol

By Lisa Kerner

Charlotte, N.C., Sept. 6 - Hythiam, Inc. was granted European Patent Number 1374952 for use of a composition of matter that underlies the company's Prometa treatment for alcohol dependence, according to a company news release.

The European patent can now be validated in 19 designated European countries.

Earlier this year, Hythiam received allowances and grants for its core intellectual property in several other countries including Australia, New Zealand, Singapore and South Africa.

Hythiam is a Los Angeles-based company that develops physiological treatments for alcoholism and other substance dependency.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.